Antibody molecules to TIM-3 and uses thereof
作者： Rosemarie H. Dekruyff , Walter A. Blattler , Catherine Anne Sabatos-Peyton , Thomas Pietzonka , Jennifer Marie Mataraza
DOI:
关键词:
摘要: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody can be used treat, prevent and/or diagnose immune, cancerous, or infectious conditions disorders.
lens.org参考文章(464)
Osamu Ohara, Fumihiko Ishikawa, Yoriko Saito, Atsushi Hijikata, Leonard D. Shultz, Hiroshi Kitamura, Hidetoshi Ozawa, Leukemia stem cell markers ,(2010)
Takeo Nomi, Masayuki Sho, Takahiro Akahori, Kaoru Hamada, Atsushi Kubo, Hiromichi Kanehiro, Shinji Nakamura, Koji Enomoto, Hideo Yagita, Miyuki Azuma, Yoshiyuki Nakajima, Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer Clinical Cancer Research. ,vol. 13, pp. 2151- 2157 ,(2007) , 10.1158/1078-0432.CCR-06-2746
Seth Alexander Ettenberg, Qing Sheng, Elizabeth Anne Reisinger Sprague, Winfried Elis, Andrew Paul Garner, Xizhong Huang, Nicole Haubst, Christian Carsten Silvester Kunz, Antibodies for epidermal growth factor receptor 3 (her3) ,(2012)
Tomohide Yamazaki, Hisaya Akiba, Hideyuki Iwai, Hironori Matsuda, Mami Aoki, Yuka Tanno, Tahiro Shin, Haruo Tsuchiya, Drew M. Pardoll, Ko Okumura, Miyuki Azuma, Hideo Yagita, Expression of Programmed Death 1 Ligands by Murine T Cells and APC Journal of Immunology. ,vol. 169, pp. 5538- 5545 ,(2002) , 10.4049/JIMMUNOL.169.10.5538
Shimpei Kasagi, Seiji Kawano, Taku Okazaki, Tasuku Honjo, Akio Morinobu, Saori Hatachi, Kenichiro Shimatani, Yoshimasa Tanaka, Nagahiro Minato, Shunichi Kumagai, Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice Journal of Immunology. ,vol. 184, pp. 2337- 2347 ,(2010) , 10.4049/JIMMUNOL.0901652
Matthew C Franklin, Kendall D Carey, Felix F Vajdos, Daniel J Leahy, Abraham M de Vos, Mark X Sliwkowski, Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex Cancer Cell. ,vol. 5, pp. 317- 328 ,(2004) , 10.1016/S1535-6108(04)00083-2
Jijie Gu, Tariq Ghayur, Peter C. Isakson, Prostaglandin e2 dual variable domain immunoglobulins and uses thereof ,(2009)
M Thomas, J D Monet, Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line. The Journal of Clinical Endocrinology and Metabolism. ,vol. 75, pp. 865- 870 ,(1992) , 10.1210/JCEM.75.3.1517379
Simone Fulda, Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application. Clinical Cancer Research. ,vol. 20, pp. 289- 295 ,(2014) , 10.1158/1078-0432.CCR-13-0227
Douglas Adam Levinson, Compositions and methods for the treatment and diagnosis of immune disorders ,(1996)